Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 17315155

A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer
Publication date
2007 Mar 15
First author
Burnett AK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2007 Mar 15;109(6):1007-10. doi: 10.1002/cncr.22502.
    note
    Source null
    related pmid
    17279580
    relationship
    Comment in

Authors and identifiers

  1. name
    Burnett AK
    type
    Author
  2. name
    Milligan D
    type
    Author
  3. name
    Prentice AG
    type
    Author
  4. name
    Goldstone AH
    type
    Author
  5. name
    McMullin MF
    type
    Author
  6. name
    Hills RK
    type
    Author
  7. name
    Wheatley K
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Burnett AK
    type
    Author
  2. name
    Milligan D
    type
    Author
  3. name
    Prentice AG
    type
    Author
  4. name
    Goldstone AH
    type
    Author
  5. name
    McMullin MF
    type
    Author
  6. name
    Hills RK
    type
    Author
  7. name
    Wheatley K
    type
    Author
bibliography ids
  1. nci-bib-c07df423b42ea9d2987cb1c1
book metadata
content sha256
83693228cc4b281b0ef4e13a2c7a56872333b18c07e5e35246d0385f3fd6df0b
document type
citation
dois
  1. 10.1002/cncr.22496
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:17315155
immutable id
pubmed:17315155@83693228cc4b281b0ef4e13a2c7a56872333b18c07e5e35246d0385f3fd6df0b
journal
abbreviation
Cancer
issn electronic
Source null
issn print
0008-543X
issue
6
name
Cancer
nlm unique id
0374236
pages
1114-24
volume
109
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Cancer. 2007 Mar 15;109(6):1007-10. doi: 10.1002/cncr.22502.
    note
    Source null
    related pmid
    17279580
    relationship
    Comment in
outcomes validated
false
pmid
17315155
provenance
batch id
e687ecc838c318f9ec65
provider
NCBI PubMed ESummary
record sha256
4715ef3ef33b712df0ed140a72904e08265206230a1b0c9c0325129ba0b3a57c
response sha256
57c28819ed5384f58bd55b57a106357c87d58ddac21f26fe526ca7520d9f61c6
retrieved at
2026-09-09T23:46:11.674833+00:00
publication date
display
2007 Mar 15
precision
day
year
2007
publication types
  1. Comparative Study
  2. Journal Article
  3. Randomized Controlled Trial
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/17315155/
title
A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.

Preserved source evidence · Not medical advice